BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10602891)

  • 21. A phase I study of 5-fluorouracil, leucovorin and levamisole.
    Cleary JF; Arzoomanian R; Alberti D; Feierabend C; Storer B; Witt P; Carbone P; Wilding G
    Cancer Chemother Pharmacol; 1997; 39(4):300-6. PubMed ID: 9025770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
    Ahnen DJ; Feigl P; Quan G; Fenoglio-Preiser C; Lovato LC; Bunn PA; Stemmerman G; Wells JD; Macdonald JS; Meyskens FL
    Cancer Res; 1998 Mar; 58(6):1149-58. PubMed ID: 9515799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and immune responses in resected colon cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.
    Foon KA; John WJ; Chakraborty M; Das R; Teitelbaum A; Garrison J; Kashala O; Chatterjee SK; Bhattacharya-Chatterjee M
    J Clin Oncol; 1999 Sep; 17(9):2889-5. PubMed ID: 10561367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant therapy for stage III colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.
    Figueredo A; Fine S; Maroun J; Walker-Dilks C; Wong S
    Cancer Prev Control; 1997 Oct; 1(4):304-19. PubMed ID: 9765754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
    Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
    J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant continuous infusion 5-FU, whole-abdominal radiation, and tumor bed boost in high-risk stage III colon carcinoma: a Southwest Oncology Group Pilot study.
    Fabian C; Giri S; Estes N; Tangen CM; Poplin E; Vogel S; Goodwin W; Rivkin S; Fleming TR; Macdonald JS
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):457-64. PubMed ID: 7751186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant chemotherapy in stage III colon cancer with 5-fluorouracil and levamisole versus 5-fluorouracil and leucovorin.
    Dencausse Y; Hartung G; Sturm J; Kopp-Schneider A; Hagmüller E; Wojatschek C; Lindemann H; Fritze D; Queisser W
    Onkologie; 2002 Oct; 25(5):426-30. PubMed ID: 12415196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levamisole and interleukin-2 for advanced malignancy.
    Holcombe RF; Li A; Stewart RM
    Biotherapy; 1998; 11(4):255-8. PubMed ID: 9950101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
    Fountzilas G; Zisiadis A; Dafni U; Konstantaras C; Hatzitheoharis G; Papavramidis S; Bousoulegas A; Basdanis G; Giannoulis E; Dokmetzioglou J; Katsohis C; Nenopoulou E; Karvounis N; Briassoulis E; Aravantinos G; Kosmidis P; Skarlos D; Pavlidis N
    Oncology; 2000 Apr; 58(3):227-36. PubMed ID: 10765125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.
    Moertel CG; Fleming TR; Macdonald JS; Haller DG; Laurie JA; Tangen CM; Ungerleider JS; Emerson WA; Tormey DC; Glick JH
    J Clin Oncol; 1995 Dec; 13(12):2936-43. PubMed ID: 8523058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic overview of chemotherapy effects in colorectal cancer.
    Ragnhammar P; Hafström L; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear maspin expression as a predictive marker for fluorouracil treatment response in colon cancer.
    Hestetun KE; Brydøy M; Myklebust MP; Dahl O
    Acta Oncol; 2015 Apr; 54(4):470-9. PubMed ID: 25227897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancer.
    Windle R; Bell PR; Shaw D
    Br J Surg; 1987 Jul; 74(7):569-72. PubMed ID: 3304518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should adjuvant chemotherapy become standard treatment for patients with stage II colon cancer? Against the proposal.
    Köhne CH
    Lancet Oncol; 2006 Jun; 7(6):516-7. PubMed ID: 16767832
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials.
    Schmoll HJ; Twelves C; Sun W; O'Connell MJ; Cartwright T; McKenna E; Saif M; Lee S; Yothers G; Haller D
    Lancet Oncol; 2014 Dec; 15(13):1481-1492. PubMed ID: 25456367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.
    O'Connell MJ; Laurie JA; Kahn M; Fitzgibbons RJ; Erlichman C; Shepherd L; Moertel CG; Kocha WI; Pazdur R; Wieand HS; Rubin J; Vukov AM; Donohue JH; Krook JE; Figueredo A
    J Clin Oncol; 1998 Jan; 16(1):295-300. PubMed ID: 9440756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant radiation therapy for colon cancer.
    Minsky BD
    Cancer Treat Rev; 1995 Sep; 21(5):407-14. PubMed ID: 8556716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological alterations induced by adjuvant treatment of postoperative colon carcinoma Duke's B or C with levamisole in combination with 5-FU.
    De Brabander M; Vandebroek J; Wassenaar H; De Crée J; Baisier A; Demoen B; De Ridder R; Jagers E; Roels V; Vogels O
    Anticancer Res; 1995; 15(5B):2271-7. PubMed ID: 8572636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adjuvant and palliative anticancer treatment of colon carcinoma in 2004].
    Medinger M; Steinbild S; Mross K
    Praxis (Bern 1994); 2004 Sep; 93(40):1633-44. PubMed ID: 15495753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant therapy of colorectal cancer.
    Kemeny N; Saltz L; Cohen A
    Surg Oncol Clin N Am; 1997 Oct; 6(4):699-722. PubMed ID: 9309089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.